Veronica Costantini

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Antiviral activity of nucleoside analogues against norovirus
    VerĂ³nica P Costantini
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Antivir Ther 17:981-91. 2012
  2. pmc Diagnostic accuracy and analytical sensitivity of IDEIA Norovirus assay for routine screening of human norovirus
    Veronica Costantini
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Mail Stop G 04, 1600 Clifton Rd, Atlanta, GA 30333, USA
    J Clin Microbiol 48:2770-8. 2010
  3. pmc Comprehensive comparison of cultivable norovirus surrogates in response to different inactivation and disinfection treatments
    Theresa Cromeans
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA CDC Foundation, Atlanta, Georgia, USA
    Appl Environ Microbiol 80:5743-51. 2014

Collaborators

Detail Information

Publications3

  1. doi request reprint Antiviral activity of nucleoside analogues against norovirus
    VerĂ³nica P Costantini
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Antivir Ther 17:981-91. 2012
    ..The lack of a cell culture has significantly hampered the development of effective therapies against human NoV. Clinically approved nucleoside and non-nucleoside analogues have been used successfully against RNA viruses...
  2. pmc Diagnostic accuracy and analytical sensitivity of IDEIA Norovirus assay for routine screening of human norovirus
    Veronica Costantini
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Mail Stop G 04, 1600 Clifton Rd, Atlanta, GA 30333, USA
    J Clin Microbiol 48:2770-8. 2010
    ..In conclusion, the current EIA may be of use as a rapid screening test during a norovirus outbreak investigation when multiple fecal samples are available; however, sporadic samples should be tested by molecular methods...
  3. pmc Comprehensive comparison of cultivable norovirus surrogates in response to different inactivation and disinfection treatments
    Theresa Cromeans
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA CDC Foundation, Atlanta, Georgia, USA
    Appl Environ Microbiol 80:5743-51. 2014
    ..Although inactivation profiles were variable for each treatment, TuV and MNV were the most resistant CSV overall and therefore are the best candidates for studying the public health outcomes of norovirus infections. ..